To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.

NCT06870422 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Esflurbiprofen Topical System

Sponsor

Teikoku Seiyaku Co., Ltd.

Collaborators

[object Object]
[object Object]
[object Object]